Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
The syndrome of apparent mineralocorticoid excess (AME) is an inherited form of human hypertension thought to result from a deficiency of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD). This enzyme normally converts cortisol to inactive cortisone and is postulated to thus confer specificity for aldosterone upon the mineralocorticoid receptor. We have analysed the gene encoding the kidney isozyme of 11 beta HSD and found mutations on both alleles in nine of 11 AME patients (eight of nine kindreds). These mutations markedly affect enzymatic activity. They thus permit cortisol to occupy the renal mineralocorticoid receptor and thereby cause sodium retention and hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [588]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Molecular basis of human hypertension: Role of angiotensinogen
Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J.-M., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90275-h · Cited by 1,850
Fetal and placental size and risk of hypertension in adult life.
Barker, D. J., Bull, A. R., Osmond, C., & Simmonds, S. J. (1990) · BMJ · doi:10.1136/bmj.301.6746.259 · Cited by 1,728
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Shimkets, R. A., Warnock, D. G., Bositis, C. M., Nelson-Williams, C., Hansson, J. H., Schambelan, M., Gill, J. R., Ulick, S., Milora, R. V., Findling, J. W., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90250-x · Cited by 1,259
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Research works printed but not linked: 3
- Werder, E., Zachmann, M., Völlmin, J.A., Veyrat, R. & Prader, A. Unusual steroid excretion in a child with low renin hypertension. Res. Steroids 6, 385–389 (1974).
- Winter, J.S.D. & McKenzie, J.K. (1977). A syndrome of low-renin hypertension in children. In Juvenile Hypertension (eds New, M.I. & Levin, L.S.) 123–133 (Raven Press, New York, 1977).
- Higuchi, R. Recombinant PCR. In PCR Protocols (eds Innis, M.A., Gelfand, D.H., Sninsky, J.J. & White, T.J.) 177–183 (Academic, San Diego,1990).
Cited by
Items 201–300 of 664
Palermo, M., Delitala, G., Mantero, F., Stewart, P. M., & Shackleton, C. H. L. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343803 · Cited by 52
Etiología y fisiopatología de la hipertensión arterial esencial
Bellido, C. M., Fernández, E., López, J. A., Simón, P. H., & Padial, L. R. (2003) · Cited by 52
The 11β hydroxysteroid dehydrogenase 2 exists as an inactive dimer
Gómez-Sánchez, E. P., Ganjam, V. K., Chen, Y. J., Liu, Y., Clark, S. A., & Gómez-Sánchez, C. E. (2001) · Steroids · doi:10.1016/s0039-128x(01)00119-2 · Cited by 51
Primary renal abnormalities in hereditary hypertension
Woolfson, R. G., & de Wardener, H. E. (1996) · Kidney International · doi:10.1038/ki.1996.370 · Cited by 52
Use of Glucocorticoids in Pregnancy
Lunghi, L., Pavan, B., Biondi, C., Paolillo, R., Valerio, A., Vesce, F., & Patella, A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793797898 · Cited by 51
The functional roles of 11β-HSD1: vascular tissue, testis and brain
Morris, D. J., Brem, A. S., Ge, R., Jellinck, P. H., Sakai, R. R., & Hardy, M. P. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00094-7 · Cited by 51
Li, K. X. Z., Smith, R. E., Ferrari, P., Funder, J. W., & Krozowski, Z. S. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03822-1 · Cited by 51
Tapia-Castillo, A., Baudrand, R., Vaidya, A., Campino, C., Allende, F. A., Valdivia, C. P., Vecchiola, A., Lagos, C. F., Fuentes, C., Solari, S., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01197 · Cited by 50
Mineralocorticoid receptors: Emerging complexity and functional diversity
Odermatt, A., & Atanasov, A. G. (2008) · Steroids · doi:10.1016/j.steroids.2008.10.010 · Cited by 50
Genetic manipulation of 11β-hydroxysteroid dehydrogenases in mice
Paterson, J. M., Seckl, J. R., & Mullins, J. J. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00017.2005 · Cited by 50
Corticosteroid-regulated genes in rat kidney: mining time series array data
Almon, R. R., Lai, W., DuBois, D. C., & Jusko, W. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00196.2005 · Cited by 50
White, P. C., Mune, T., Rogerson, F. M., Kayes, K. M., & Agarwal, A. K. (1997) · Steroids · doi:10.1016/s0039-128x(96)00164-x · Cited by 50
Self-citationNormokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit, S., Bernheim, J., & Podjarny, E. (2002) · PubMed · Cited by 50
Primary aldosteronism: Part II: subtype differentiation and treatment
Rossi, G. P., Seccia, T. M., & Pessina, A. C. (2007) · Journal of Nephrology · doi:10.1093/joneph/21.4.455 · Cited by 49
11β-Hydroxysteroid Dehydrogenase and Its Role in the Syndrome of Apparent Mineralocorticoid Excess
White, P. C., Mune, T., Rogerson, F. M., Kayes, K. M., & Agarwal, A. K. (1997) · Pediatric Research · doi:10.1203/00006450-199701000-00004 · Cited by 49
Self-citationMonogenic forms of low-renin hypertension
Garovic, V. D., Hilliard, A. A., & Turner, S. T. (2006) · Nature Reviews Nephrology · doi:10.1038/ncpneph0309 · Cited by 49
Genetics of arterial hypertension and hypotension
Rosskopf, D., Schürks, M., Rimmbach, C., & Schäfers, R. F. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0133-2 · Cited by 49
Aldosterone, Salt and Cardiac Fibrosis
Funder, J. W. (1997) · Clinical and Experimental Hypertension · doi:10.3109/10641969709083193 · Cited by 49
Cortisol as a mineralocorticoid in human disease
Stewart, P. M. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00072-2 · Cited by 49
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics
Lu, Y., Zhang, D., Zhang, Q.-Y., Zhou, Z.-M., Yang, K., Zhou, X., & Peng, F. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03698-9 · Cited by 48
Campino, C., Carvajal, C. A., Cornejo, J., Martín, B. S., Olivieri, O., Guidi, G. C., Faccini, G., Pasini, F., Sateler, J., Baudrand, R. F., et al. (2009) · Endocrine · doi:10.1007/s12020-009-9269-9 · Cited by 48
Yang, K., Khalil, M. W., Strutt, B. J., & KILLINGER, D. W. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00187-2 · Cited by 48
Ionizing radiation and genetic risks
Sankaranarayanan, K., Chakraborty, R., & Boerwinkle, E. (1999) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(98)00017-9 · Cited by 48
Genetics of Hypertensive Syndrome
Martínez‐Aguayo, A., & Fardella, C. (2009) · Hormone Research in Paediatrics · doi:10.1159/000208798 · Cited by 47
11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Chapman, K. E., & Seckl, J. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9504-9 · Cited by 47
Genetics of Hypertension: Therapeutic Implications
O???Byrne, S., & Caulfield, M. J. (1998) · Drugs · doi:10.2165/00003495-199856020-00004 · Cited by 47
Tang, J. I., Kenyon, C. J., Seckl, J. R., & Nyirenda, M. J. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328340aa18 · Cited by 42
Genetics of Human Hypertension
Ruppert, V., & Maisch, B. (2003) · Herz · doi:10.1007/s00059-003-2516-6 · Cited by 46
Inoue, T., Okauchi, Y., Matsuzaki, Y., Kuwajima, K., Kondo, H., Horiuchi, N., Nakao, K., Iwata, M., Yokogoshi, Y., Shintani, Y., et al. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380691 · Cited by 45
Kitanaka, S., Katsumata, N., Tanae, A., Hibi, I., Takeyama, K.-I., Fuse, H., Kato, S., & Tanaka, T. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4455 · Cited by 38
Li, K. X. Z., Obeyesekere, V. R., Krozowski, Z. S., & Ferrari, P. (1997) · Endocrinology · doi:10.1210/endo.138.7.5232 · Cited by 44
Pure 16q21q22.1 deletion in a complex rearrangement possibly caused by a chromothripsis event
Genesio, R., Ronga, V., Castelluccio, P., Fioretti, G., Mormile, A., Leone, G., Conti, A. M. F., Cavaliere, M. L., & Nitsch, L. (2013) · Molecular Cytogenetics · doi:10.1186/1755-8166-6-29 · Cited by 44
Hult, M., Shafqat, N., Elleby, B., Mitschke, D., Svensson, S., Forsgren, M., Barf, T. A., Vallgårda, J., Abrahmsén, L., & Oppermann, U. C. T. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.043 · Cited by 44
Ueda, K., Nishimoto, M., Hirohama, D., Ayuzawa, N., Kawarazaki, W., Watanabe, A., Shimosawa, T., Loffing, J., Zhang, M.-Z., Marumo, T., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08966 · Cited by 44
Salt-sensitive hypertension: Lessons from animal models
Sanders, P. W. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90265-6 · Cited by 44
In search of hypertension genes in Dahl salt-sensitive rats
Deng, A. Y. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816120-00001 · Cited by 44
Liddle syndrome in a Serbian family and literature review of underlying mutations
Bogdanović, R., Kuburović, V., Stajić, N., Mughal, S. S., Hilger, A. C., Ninić, S., Prijić, S., & Ludwig, M. Z. (2011) · European Journal of Pediatrics · doi:10.1007/s00431-011-1581-8 · Cited by 43
The role of 11β-hydroxysteroid dehydrogenase in steroid hormone specificity
Náray‐Fejes‐Tóth, A., Colombowala, I. K., & Fejes‐Tóth, G. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00009-0 · Cited by 43
Gómez-Sánchez, E. P., Ganjam, V. K., Chen, Y. J., Cox, D. L., Zhou, M.-Y., Thanigaraj, S., & Gómez-Sánchez, C. E. (1997) · Steroids · doi:10.1016/s0039-128x(97)00011-1 · Cited by 43
SPAK and WNK kinases: a new target for blood pressure treatment?
Glover, M., & O’Shaughnessy, K. M. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32834132bc · Cited by 42
Drug-induced endocrine blood pressure elevation
Beck, K. R., Thompson, G. R., & Odermatt, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104311 · Cited by 42
Surgically correctable hypertension caused by primary aldosteronism
Rossi, G. P. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.003 · Cited by 43
Effect of glucocorticoid excess on the cortisol/cortisone ratio
Dötsch, J., Dörr, H. G., Stalla, G. K., & Sippell, W. G. (2001) · Steroids · doi:10.1016/s0039-128x(01)00117-9 · Cited by 42
Maser, E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01090-0 · Cited by 42
Koyama, K., Myles, K., Smith, R., & Krozowski, Z. S. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00157-6 · Cited by 41
Steroids - From Physiology to Clinical Medicine
Ostojić, S. M. (2012) · InTech eBooks · doi:10.5772/46119 · Cited by 41
Molecular basis for the Apparent Mineralocorticoid Excess Syndrome in the Oman population
Quinkler, M. O., Bappal, B., Draper, N. R., Atterbury, A., Lavery, G. G., Walker, E. A., Desilva, V. R., Taylor, N., Hala, S., Rajendra, N., et al. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.019 · Cited by 41
Gómez-Sánchez, E. P., Cox, D. S., Foecking, M. F., Ganjam, V. K., & Gómez-Sánchez, C. E. (1996) · Steroids · doi:10.1016/0039-128x(95)00201-z · Cited by 41
Gray, C., Al‐Dujaili, E. A. S., Sparrow, A. J., Gardiner, S. M., Craigon, J., Welham, S. J. M., & Gardner, D. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072682 · Cited by 40
Virtual screening applications in short-chain dehydrogenase/reductase research
Beck, K. R., Kaserer, T., Schuster, D., & Odermatt, A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.008 · Cited by 40
Carvajal, C. A., Romero, D. N. G., Mosso, L. M., lez, A. G., Campino, C., Montero, J., & Fardella, C. (2005) · Journal of Hypertension · doi:10.1097/00004872-200501000-00015 · Cited by 40
Asao, T., Oki, K., Yoneda, M., Tanaka, J., & Kohno, N. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0360 · Cited by 40
Latif, S. A., Sheff, M. F., Ribeiro, C. E., & Morris, D. J. (1997) · Steroids · doi:10.1016/s0039-128x(96)00208-5 · Cited by 40
Blood pressure and human genetic variation in the general population
Arora, P. K., & Newton‐Cheh, C. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283383e2c · Cited by 40
Kreutz, R. H., Zuurman, M. W., Kain, S., Bolbrinker, J., de Jong, P. E., & Navis, G. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200512000-00001 · Cited by 39
Hormonal Hypertension in Children: 11β-Hydroxylase Deficiency and Apparent Mineralocorticoid Excess
Cerame, B. I., & New, M. I. (2000) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2000.13.9.1537 · Cited by 39
The Role of Aldosterone in Renal Sodium Transport
Rozansky, D. J. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.09.008 · Cited by 39
Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides
Williams, T. A., Mulatero, P., Filigheddu, F., Troffa, C., Milan, A., Argiolas, G., Parpaglia, P. P., Veglio, F., & Glorioso, N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67119.x · Cited by 39
Perhydroquinolylbenzamides as Novel Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Coppola, G. M., Kukkola, P. J., Stanton, J. L., Neubert, A. D., Marcopulos, N., Bilci, N. A., Wang, H., Tomaselli, H. C., Tan, J., Aicher, T. D., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058228q · Cited by 39
Genetic Determination of Human Essential Hypertension
Matsubara, M. (2000) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.192.19 · Cited by 38
Mapping of a Blood Pressure Quantitative Trait Locus to Chromosome 15q in a Chinese Population
Xu, X., Yang, J., Rogus, J. J., Chen, C., Schork, N. J., & Xu, X. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.13.2551 · Cited by 38
Ma, C., Yu, B., Zhang, W., Wang, W., Zhang, L., & Zeng, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-11071-w · Cited by 37
Clinical and Molecular Perspectives of Monogenic Hypertension
Levanovich, P., Diaczok, A., & Rossi, N. F. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190409115330 · Cited by 38
Pizzolo, F., Friso, S., Morandini, F., Antoniazzi, F., Zaltron, C., Udali, S., Gandini, A., Cavarzere, P., Salvagno, G. L., Giorgetti, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1760 · Cited by 37
Pseudohyperaldosteronism: Pathogenetic Mechanisms
Armanini, D., Calò, L. A., & Semplicini, A. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609355 · Cited by 37
Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 in Obesity
Wake, D. J., & Walker, B. R. (2006) · Endocrine · doi:10.1385/endo:29:1:101 · Cited by 37
The role of the kidney and the sympathetic nervous system in hypertension
Thomas, P., & Dasgupta, I. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2789-4 · Cited by 36
Tubular Disorders of Electrolyte Regulation
Devuyst, O., Konrad, M., Jeunemaître, X., & Zennaro, M. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_38 · Cited by 36
Genetic determinants of hypertension: An update
Harrison, M., Maresso, K. C., & Broeckel, U. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0091-1 · Cited by 36
Apparent mineralocorticoid excess and the long term treatment of genetic hypertension
Razzaghy‐Azar, M., Yau, M., Khattab, A., & New, M. I. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.014 · Cited by 36
Wu, A., Wolley, M. J., & Stowasser, M. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0170-6 · Cited by 36
Sugiyama, T., Kato, N., Ishinaga, Y., Yamori, Y., & Yazaki, Y. (2001) · Hypertension Research · doi:10.1291/hypres.24.515 · Cited by 36
Agarwal, A. K., & White, P. C. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03855-5 · Cited by 36
Self-citationStewart, P. M. (2005) · Clinical Medicine · doi:10.7861/clinmedicine.5-2-142 · Cited by 35
Iozzo, P., Holmes, M. C., Schmidt, M. V., Cirulli, F., Guzzardi, M. A., Berry, A., Balsevich, G., Andreassi, M. G., Wesselink, J., Liistro, T., et al. (2014) · Obesity Facts · doi:10.1159/000362656 · Cited by 35
Monogenic forms of human hypertension
Toka, H. R., & Luft, F. C. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.30206 · Cited by 35
VASCULAR LOCALIZATION OF THE 11β‐HYDROXYSTEROID DEHYDROGENASE TYPE II ENZYME
Smith, R. E., Little, P. J., Maguire, J. A., Stein‐Oakley, A. N., & Krozowski, Z. S. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02776.x · Cited by 31
Implication of ENaC in salt-sensitive hypertension
Hümmler, E. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00073-4 · Cited by 34
Genetic Factors in Hypertension – What is Known and What Does It Mean?
Melander, O. (2001) · Blood Pressure · doi:10.1080/080370501753400575 · Cited by 34
Advances in the neurophysiology of magnocellular neuroendocrine cells
Tasker, J. G., Prager‐Khoutorsky, M., Teruyama, R., Lémos, J. R., & Armstrong, W. E. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12826 · Cited by 33
Monogenic forms of low-renin hypertension: clinical and molecular insights
Khandelwal, P., & Deinum, J. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05246-x · Cited by 34
Modulation of Renal Calcium Handling by 11β-Hydroxysteroid Dehydrogenase Type 2
Ferrari, P., Bianchetti, M. G., Sansonnens, A., & Frey, F. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000028640.78526.0f · Cited by 33
Mineralocorticoid Action in the Aldosterone-Sensitive Distal Nephron
Verrey, F., Hümmler, E., Schild, L., & Rossier, B. C. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50035-8 · Cited by 34
11β-Hydroxysteroid dehydrogenase in human vascular cells
Hatakeyama, H., Inaba, S., Takeda, R., & Miyamori, I. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00974.x · Cited by 33
A second enzyme protecting mineralocorticoid receptors from glucocorticoid occupancy
Morris, D. J., Latif, S. A., Rokaw, M. D., Watlington, C. O., & Johnson, J. P. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.5.c1245 · Cited by 33
Takeda, Y., Miyamori, I., Iki, K., Inaba, S., Furukawa, K., Hatakeyama, H., Yoneda, T., & Takeda, R. (1996) · Hypertension · doi:10.1161/01.hyp.27.2.197 · Cited by 33
The molecular basis of blood pressure variation
Toka, H. R., Koshy, J. M., & Hariri, A. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2206-9 · Cited by 32
The cross talk of adrenal and Leydig cell steroids in Leydig cells
Wang, Y., Li, H., Zhu, Q., Li, X., Lin, Z., & Ge, R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105386 · Cited by 32
In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence
Manning, J. R., Bailey, M. A., Soares, D. C., Dunbar, D. R., & Mullins, J. J. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00053.2010 · Cited by 32
Kasuya, Y., Shibasaki, H., & Furuta, T. (2000) · Steroids · doi:10.1016/s0039-128x(99)00086-0 · Cited by 32
Interactions between 11β-hydroxysteroid dehydrogenase and COX-2 in kidney
Yao, B., Harris, R. C., & Zhang, M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00786.2004 · Cited by 32
Pathophysiology of adrenal hypertension
Moneva, M. H., & Gómez-Sánchez, C. E. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.28670 · Cited by 32
Effects of spironolactone on systolic blood pressure in experimental diabetic rats
Liu, Y.-J., Nakagawa, Y., Toya, K., Wang, Y., Saegusa, H., Nakanishi, T., & Ohzeki, T. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00055.x · Cited by 32
Obeyesekere, V. R., Li, K. X. Z., Ferrari, P., & Krozowski, Z. S. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00106-8 · Cited by 32
Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine
Nakagawa, K., & Ishizaki, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00066-2 · Cited by 31
Overview of Monogenic Forms of Hypertension Combined With Hypokalemia
Lu, Y., Fan, P. T., Zhang, D., Zhang, Y., Meng, X., Zhang, Q.-Y., Zhao, L. Y., Yang, K., & Zhou, X. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.543309 · Cited by 32
Clinical Relevance of Airway 11 β -Hydroxysteroid Dehydrogenase Type II Enzyme in Asthma
Orsida, B., Krozowski, Z. S., & Walters, E. H. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2105003 · Cited by 30
Pathophysiology of Hypertension
Yamaguchi, I., & Flynn, J. T. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_61 · Cited by 30
Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats
Usa, K., Singh, R., Netzel, B. C., Liu, Y., Raff, H., & Liang, M. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00484.2006 · Cited by 30
Analysis of the human gene encoding the kidney isozyme of 11β-hydroxysteroid dehydrogenase
Agarwal, A. K., Rogerson, F. M., Mune, T., & White, P. C. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00196-4 · Cited by 30
Self-citation
Metadata
- Authors
- Mune, T., Rogerson, F. M., Nikkilä, H., Agarwal, A. K., & White, P. C.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature Genetics
- Published
- 1995-08-01
- Volume
- 10
- Issue
- 4
- Pages
- 394-399
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2034652601
- Semantic Scholar
- 39186032ea056bd01960beb7624e326d14d1cda1
- Cited by
- 619
- References
- 57
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 10 · 2022: 4 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 9 · 2017: 13 · 2016: 15 · 2015: 16 · 2014: 13 · 2013: 15 · 2012: 15
- FWCI
- 33.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk034400-10, 5r01dk042169-12)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42169, DK-34400)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- apparent mineralocorticoid excess, hypertension, 11β-hydroxysteroid dehydrogenase, genetic mutations, mineralocorticoid receptor, cortisol, aldosterone, sodium retention, genetic hypertension, kindred
- MeSH terms
- Adolescent, Adult, Base Sequence, Child, Child, Preschool, Female, Humans, Hydroxysteroid Dehydrogenases, Hypertension, Infant, Infant, Low Birth Weight, Infant, Newborn, Isoenzymes, Kidney, Male, Mineralocorticoids, Molecular Sequence Data, Mutation, Risk Factors, DNA Primers, 11-beta-Hydroxysteroid Dehydrogenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.